From: Outcome of severe lactic acidosis associated with metformin accumulation
All patients (n= 197) | MALA (n= 10) | LAOO (n= 187) | Post-cardiac arrest (n= 72) | Septic shock (n= 42) | Cardiogenic shock (n= 39) | Mesenteric ischemia (n= 8) | Hemorrhagic shock (n= 13) | Other causes (n= 13) | |
---|---|---|---|---|---|---|---|---|---|
Age, years | 67 ± 13 | 66 ± 9 | 67 ± 13 | 65 ± 13 | 68 ± 12 | 73 ± 11 | 72 ± 9 | 64 ± 15 | 56 ± 14 |
Male gender | 121 (61%) | 4 (40%) | 117 (63%) | 45 (62%) | 24 (57%) | 26 (67%) | 6 (75%) | 7 (54%) | 9 (69%) |
SAPS II | 74 ± 20 | 88 ± 23 | 73 ± 19a | 81 ± 16 | 71 ± 19a | 75 ± 18 | 73 ± 25 | 54 ± 15b | 54 ± 14b |
SOFA score | 12.5 ± 3.6 | 14.3 ± 1.4 | 12.4 ± 3.7 | 12.9 ± 2.9 | 12.1 ± 4.5 | 11.8 ± 2.8b | 14.4 ± 4.4 | 13.4 ± 4.6 | 9.6 ± 4.2b |
Respiratory | 2.5 ± 1.0 | 2.7 ± 0.9 | 2.5 ± 1.0 | 2.7 ± 0.9 | 2.1 ± 1.3 | 2.4 ± 0.6 | 2.6 ± 1.1 | 2.3 ± 1.5 | 2.2 ± 1.4 |
Renal | 2.4 ± 1.2 | 4.0 ± 0.0 | 2.3 ± 1.2b | 2.1 ± 1.2b | 2.5 ± 1.2b | 2.5 ± 1.1b | 2.8 ± 0.8a | 2.1 ± 1.5b | 1.9 ± 1.3b |
Hepatic | 0.7 ± 1.0 | 0.3 ± 0.7 | 0.7 ± 1.0 | 0.3 ± 0.6 | 1.3 ± 1.2a | 0.6 ± 0.8 | 0.6 ± 0.9 | 1.8 ± 1.7 | 0.9 ± 0.9 |
Cardiovascular | 3.3 ± 1.4 | 4.0 ± 0.0 | 3.3 ± 1.5 | 3.5 ± 1.3 | 3.2 ± 1.5 | 3.4 ± 1.5 | 4.0 ± 0.0 | 2.9 ± 1.8 | 2.1 ± 2.0a |
Hematologic | 0.9 ± 1.2 | 0.5 ± 0.8 | 0.9 ± 1.2 | 0.6 ± 0.9 | 1.3 ± 1.4 | 0.3 ± 0.7 | 2.2 ± 1.6 | 2.6 ± 1.1 | 0.9 ± 1.2 |
Neurologic | 2.7 ± 1.4 | 2.8 ± 1.5 | 2.7 ± 1.4 | 3.7 ± 0.6a | 1.7 ± 1.3a | 2.8 ± 1.2 | 2.2 ± 1.3 | 1.8 ± 1.4b | 1.6 ± 1.2 |
Lactate, mmol/L | 11.6 ± 6.2 | 18.7 ± 5.3 | 11.2 ± 6.1b | 12.8 ± 6.1b | 8.7 ± 4.5b | 10.9 ± 5.2b | 8.6 ± 3.3b | 13.5 ± 9.5b | 10.8 ± 7.1b |
pH | 7.13 ± 0.19 | 6.75 ± 0.13 | 7.15 ± 0.17b | 7.07 ± 0.19b | 7.23 ± 0.09b | 7.18 ± 0.14b | 7.27 ± 0.04b | 7.26 ± 0.07b | 7.14 ± 0.18b |
Bicarbonate, mmol/L | 14.6 ± 5.9 | 4.4 ± 2.4 | 15.2 ± 5.6b | 14.5 ± 5.6b | 16.6 ± 5.8b | 14.9 ± 4.0b | 16.2 ± 1.8b | 15.8 ± 5.7b | 14.1 ± 8.8b |
Creatinine, μmol/L | 307 ± 265 | 796 ± 324 | 227 ± 141b | 169 ± 128b | 318 ± 181b | 182 ± 48b | 299 ± 125a | 303 ± 122a | 214 ± 57b |
Survival | 52 (26%) | 5 (50%) | 48 (26%) | 19 (26%) | 9 (21%) | 9 (23%) | 0 | 5 (38%) | 6 (46%) |